Evan Dorian Archive

March 17, 2025

Latest edition of stroke symposium coming to Vanderbilt April 17 

With stroke care evolving rapidly, the event aims to improve stroke care in Middle Tennessee and beyond through continuing medical education.

(iStock)
March 11, 2025

Thinking outside the (voice) box: VUMC surgeons have all the pieces in place for the complex puzzle of laryngeal transplantation 

Only a few laryngeal transplants have been successfully performed in the United States. Now, surgeons at Vanderbilt University Medical Center are ready for their first patient.

February 21, 2025

Thoughtful, proactive and always full of cheer, Soraida Chavez is the glue that holds the Vanderbilt Benign Hematology Clinic together

“Soraida is one of the main reasons why we have such high patient and provider satisfaction in the benign hematology clinic,” wrote one nominator. “She is a wonderful, caring person who takes care of both the patients and the clinical staff.”

Tara Overbeeke, MD, left, poses for a photo with Jessica Mason, MD, and son, Myles, who received his white coat at VUMC EM Family Day. (photo by Donn Jones)
February 14, 2025

Emergency department hosts first VUMC EM Family Day 

Family and friends of emergency physicians and administrative staff were invited to experience a day in the life of an emergency physician.

January 27, 2025

Personalized, image-guided approach to programming may improve music perception abilities for patients with cochlear implants

As research in cochlear implant stimulation expands to include music perception, clearing up channel interaction remains the focal point as audiologists aim to customize how electrodes stimulate the auditory nerve to improve patients’ ability to hear music.

Bill Russell, MD, left, with patient and trial participant Spencer Mannahan and his father, Zach. (photo by Evan Dorian)
January 22, 2025

Milestone in VUMC-affiliated diabetes screening and research program underscores impact of clinical trials

Screening and clinical trials are further advancing research to develop therapies that delay or prevent the progression to clinical disease in people at risk of developing Type 1 diabetes.